Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
Use this PYXS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PYXS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PYXS SEC filings page. Lician reads the product cache first so this HTML stays unique to Pyxis Oncology Inc even when a live quote feed is slow.
Latest cached year on this hub. Full PYXS income, balance, and cash tables.